Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

NCT05524935 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma
Ocular Melanoma

Interventions

DRUG: Pembrolizumab
DRUG: Olaparib

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]